Patrick Doyle is the CEO of Stelexis Therapeutics, a private biotechnology company based in New York. Patrick spoke with us about the company and the future of cancer treatments. What recent advancements have you seen in cancer therapeutics? Although it has fast become a crowded field, areas such as Immune oncology including CAR-T, checkpoint […]
CEO Today Online and CEO Today magazine are dedicated to providing CEOs and C-level executives with the latest corporate developments, business news and technological innovations.
